Manufacturer or GPO Program year 2025 Source: CMS Open Payments

AstraZeneca Pharmaceuticals LP

DE, United States

CMS manufacturer 100000000146

Open in the dashboard

General payments

$455,882,965

3,228,979 payments

Research payments

$2,513,126,992

43,708 payments

Ownership & investment interest

$0

None reported

Through program year 2025, AstraZeneca Pharmaceuticals LP reported paying $455,882,965 in general payments and $2,513,126,992 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $69,553,694 555,048
2025 Research $476,405,582 6,790
2024 General $64,724,187 614,064
2024 Research $363,443,522 5,774
2023 General $57,247,929 464,707
2023 Research $333,207,048 5,201
2022 General $48,174,051 434,192
2022 Research $359,327,628 5,156
2021 General $75,691,974 436,207
2021 Research $397,435,754 6,845
2020 General $68,404,669 309,511
2020 Research $335,676,453 6,549
2019 General $72,086,460 415,250
2019 Research $247,631,005 7,393

Breakdown

Top recipients General payments · program year 2025
  1. Dana-Farber Cancer Institute Teaching hospital · MA $9,367,802 39 payments
  2. National Jewish Health Teaching hospital · CO $1,345,989 13 payments
  3. Hospital Of The Univ Of Penna Teaching hospital · PA $1,127,427 26 payments
  4. Howard University Hospital Teaching hospital · DC $664,050 6 payments
  5. Strong Memorial Hospital Teaching hospital · NY $630,641 39 payments
  6. Univ Of Mi Hospitals & Hlth Ctrs Teaching hospital · MI $607,189 13 payments
  7. Rush University Medical Center Teaching hospital · IL $351,770 4 payments
  8. Ronald Reagan Ucla Teaching hospital · CA $337,122 7 payments
  9. Anthony Mato Medical Oncology · Ithaca, NY $303,402 5 payments
  10. Moffitt Cancer Center Teaching hospital · FL $299,500 10 payments
Top research recipients Research payments · program year 2025
  1. Ut Md Anderson Cancer Center Teaching hospital · TX $31,212,325 54 payments
  2. Memorial Sloan Kettering Cancer Center $16,476,293 37 payments
  3. Dana Farber Partners Cancer Care $13,760,852 40 payments
  4. Velocity Clinical Research $9,945,070 230 payments
  5. Dana Farber Cancer Institute, INC $9,567,459 34 payments
  6. Mayo Clinic Pediatric Hematology Oncology $9,111,666 31 payments
  7. Sarah Cannon Research Institute $8,597,366 171 payments
  8. Kfh - Santa Clara Teaching hospital · CA $6,806,015 5 payments
  9. Sarah Cannon Research Institute LLC $6,621,137 158 payments
  10. Crn Clinical Research Network $6,523,703 94 payments
Products the payments named General payments · program year 2025
  1. Airsupra Respiratory $11,348,240 21% · 56,132 recipients
  2. Imfinzi Oncology $11,301,233 20% · 6,951 recipients
  3. Breztri Respiratory $7,489,836 14% · 39,628 recipients
  4. Tezspire Respiratory $5,167,543 9% · 10,314 recipients
  5. Fasenra Respiratory $4,341,985 8% · 10,449 recipients

The top 5 of 34 products; each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

The top 25 products, free in the app

Specialties paid General payments · program year 2025
  1. Pulmonary Disease Internal Medicine $8,328,375 16% · 4,209 practitioners
  2. Hematology & Oncology Internal Medicine $6,589,357 13% · 4,307 practitioners
  3. Allergy & Immunology $5,605,427 11% · 1,699 practitioners
  4. Medical Oncology Internal Medicine $3,495,942 7% · 1,581 practitioners
  5. Internal Medicine $3,369,219 7% · 14,120 practitioners

The top 5 of 251 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Massachusetts $10,922,413 16% · 1,645 recipients
  2. California $6,737,347 10% · 9,718 recipients
  3. New York $5,027,835 7% · 8,020 recipients
  4. Florida $4,945,886 7% · 11,484 recipients
  5. Texas $3,890,663 6% · 11,530 recipients

The top 5 of 54 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $161,075,202 76,116 payments
  2. Royalty or License $100,077,178 51 payments
  3. Food and Beverage $82,381,209 3,033,077 payments
  4. Consulting Fee $64,118,568 25,431 payments
  5. Travel and Lodging $16,663,180 55,983 payments
  6. Grant $15,053,454 688 payments
  7. Charitable Contribution $8,420,262 494 payments
  8. Space rental or facility fees (teaching hospital only) $6,474,422 3,156 payments
  9. Education $991,113 33,667 payments
  10. Gift $533,224 32 payments
Companies with a similar name General payments · program years 2019–2025
  1. AstraZeneca UK Limited Great Britain (UK) $75,869,023
  2. AstraZeneca AB Sweden $6,784,321

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

3,228,979 general · 43,708 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record